Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5–11 Years of Age, Israel
Emerging Infectious Diseases · 2023-04 · 29 (4) · 771-777
DOI: 10.3201/eid2904.221285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2023-04. Verfasst von Aharona Glatman-Freedman und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: COVID-19, Vaccines. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Glatman-Freedman, A., Hershkovitz, Y., Dichtiar, R., Rosenberg, A., Keinan-Boker, L., & Bromberg, M. (2023). Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5–11 Years of Age, Israel. Emerging Infectious Diseases, 29(4), 771-777. https://doi.org/10.3201/eid2904.221285
Vancouver
Glatman-Freedman A, Hershkovitz Y, Dichtiar R, Rosenberg A, Keinan-Boker L, Bromberg M. Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5–11 Years of Age, Israel. Emerging Infectious Diseases. 2023;29(4):771-777. doi:10.3201/eid2904.221285
BibTeX
@article{GlatmanFreedman2023,
author = {Glatman-Freedman, Aharona and Hershkovitz, Yael and Dichtiar, Rita and Rosenberg, Alina and Keinan-Boker, Lital and Bromberg, Michal},
title = {Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5–11 Years of Age, Israel},
journal = {Emerging Infectious Diseases},
year = {2023},
volume = {29},
number = {4},
pages = {771--777},
doi = {10.3201/eid2904.221285}
}
EUVIMED